Matsuo M - Search Results

1

Immune Checkpoint Inhibitors for Nasopharyngeal Carcinoma in a Real-world Setting in Japan.

Manako T, Yasumatsu R, Nakano T, Matsuo M, Takeuchi T, Taura M, Tamae A, Yamauchi M, Masuda M, Taguchi K, Nakagawa T. Manako T, et al. Among authors: matsuo m. In Vivo. 2023 Mar-Apr;37(2):747-755. doi: 10.21873/invivo.13137. In Vivo. 2023. PMID: 36881083 Free PMC article.

2

Utility of algorithm-based chemoradioselection in the treatment for advanced hypopharyngeal carcinoma.

Masuda M, Matsuo M, Aso T, Kiyohara H, Rikimaru F, Kunitake N, Higaki Y. Masuda M, et al. Among authors: matsuo m. Head Neck. 2015 Sep;37(9):1290-6. doi: 10.1002/hed.23759. Epub 2014 Jul 24. Head Neck. 2015. PMID: 24816950

3

Induction of CD44 variant 9-expressing cancer stem cells might attenuate the efficacy of chemoradioselection and Worsens the prognosis of patients with advanced head and neck cancer.

Aso T, Matsuo M, Kiyohara H, Taguchi K, Rikimaru F, Shimokawa M, Segawa Y, Higaki Y, Umeno H, Nakashima T, Masuda M. Aso T, et al. Among authors: matsuo m. PLoS One. 2015 Mar 9;10(3):e0116596. doi: 10.1371/journal.pone.0116596. eCollection 2015. PLoS One. 2015. PMID: 25751671 Free PMC article.

4

[Spindle Cell Carcinoma of the Head and Neck: A Report of 6 Cases].

Matsuo M, Rikimaru F, Higaki Y, Masuda M. Matsuo M, et al. Nihon Jibiinkoka Gakkai Kaiho. 2015 Feb;118(2):123-8. doi: 10.3950/jibiinkoka.118.123. Nihon Jibiinkoka Gakkai Kaiho. 2015. PMID: 26336792 Japanese.

5

A case of hypopharyngeal cancer with stenosis, perforation, and pyogenic spondylitis development after chemoradiotherapy.

Matsuo M, Rikimaru F, Higaki Y, Masuda M. Matsuo M, et al. Int J Surg Case Rep. 2016;20:104-8. doi: 10.1016/j.ijscr.2016.01.020. Epub 2016 Jan 22. Int J Surg Case Rep. 2016. PMID: 26829460 Free PMC article.

6

The treatment and outcome analysis of primary squamous cell carcinoma of the thyroid.

Yasumatsu R, Sato M, Uchi R, Nakano T, Hashimoto K, Kogo R, Taura M, Matsuo M, Nakashima T, Nakagawa T. Yasumatsu R, et al. Among authors: matsuo m. Auris Nasus Larynx. 2018 Jun;45(3):553-557. doi: 10.1016/j.anl.2017.07.009. Epub 2017 Jul 22. Auris Nasus Larynx. 2018. PMID: 28739190

7

Monitoring the neutrophil-to-lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer.

Yasumatsu R, Wakasaki T, Hashimoto K, Nakashima K, Manako T, Taura M, Matsuo M, Nakagawa T. Yasumatsu R, et al. Among authors: matsuo m. Head Neck. 2019 Aug;41(8):2610-2618. doi: 10.1002/hed.25737. Epub 2019 Mar 5. Head Neck. 2019. PMID: 30835919

8

Outcome of chemotherapy following nivolumab treatment for recurrent and/or metastatic head and neck squamous cell carcinoma.

Wakasaki T, Yasumatsu R, Uchi R, Taura M, Matsuo M, Komune N, Nakagawa T. Wakasaki T, et al. Among authors: matsuo m. Auris Nasus Larynx. 2020 Feb;47(1):116-122. doi: 10.1016/j.anl.2019.05.001. Epub 2019 May 23. Auris Nasus Larynx. 2020. PMID: 31128940

9

Small Cell Carcinoma in the Head and Neck.

Wakasaki T, Yasumatsu R, Masuda M, Matsuo M, Tamae A, Kubo K, Kogo R, Uchi R, Taura M, Nakagawa T. Wakasaki T, et al. Among authors: matsuo m. Ann Otol Rhinol Laryngol. 2019 Nov;128(11):1006-1012. doi: 10.1177/0003489419853601. Epub 2019 Jun 4. Ann Otol Rhinol Laryngol. 2019. PMID: 31161776

10

Utility of negative-pressure wound therapy for orocutaneous and pharyngocutaneous fistula following head and neck surgery.

Inatomi Y, Kadota H, Yoshida S, Kamizono K, Shimamoto R, Fukushima S, Miyashita K, Matsuo M, Yasumatsu R, Tanaka S, Fukushima J. Inatomi Y, et al. Among authors: matsuo m. Head Neck. 2020 Jan;42(1):103-110. doi: 10.1002/hed.25989. Epub 2019 Oct 16. Head Neck. 2020. PMID: 31617619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,077 results

Search Page